|
|
| | Creatine riboside Basic information |
| Product Name: | Creatine riboside | | Synonyms: | Creatine riboside;2-{2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-
oxolan-2-yl]-1-methylcarbamimidamido}acetic acid;Creatine riboside N-(N-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)carbamimidoyl)-N-methylglycine;Glycine, N-[imino(β-D-ribofuranosylamino)methyl]-N-methyl- | | CAS: | 1616693-92-5 | | MF: | C9H17N3O6 | | MW: | 263.24778 | | EINECS: | | | Product Categories: | | | Mol File: | 1616693-92-5.mol |  |
| | Creatine riboside Chemical Properties |
| Boiling point | 525.2±60.0 °C(Predicted) | | density | 1.71±0.1 g/cm3(Predicted) | | pka | 3.40±0.10(Predicted) |
| | Creatine riboside Usage And Synthesis |
| Description | Creatine riboside (CR) is a novel metabolite of cancer metabolism. It is a urinary diagnostic biomarker of lung and liver cancer risk and prognosis. The level of CR is highly positive correlated in tumor and urine indicating that it is derived from human lung and liver cancers. |
| | Creatine riboside Preparation Products And Raw materials |
|